Suppr超能文献

在国家结核病和肺部疾病研究所接受治疗的结核病患者中异烟肼乙酰化的类型

The type of isoniazid acetylation in tuberculosis patients treated at National Tuberculosis and Lung Diseases Research Institute.

作者信息

Augustynowicz-Kopeć Ewa, Zwolska Zofia

机构信息

National Tuberculosis and Lung Diseases Research Institute, 26 Płocka Str., 01-138 Warsaw, Poland.

出版信息

Acta Pol Pharm. 2002 Nov-Dec;59(6):443-7.

Abstract

The research has dealt with types of acetylation in 237 TB patients treated by standard course of chemotherapy with a 300 mg dose of INH at the National Tuberculosis and Lung Diseases Research Institute in Warsaw (NTLDRI). Blood samples were taken before (time 0) and 1, 3, 6 and 24 h after drug administration. Plasma concentrations of isoniazid were determined with biological methods. Two indicators of acetylation rate--I3 and C6 have been used to determine the acetylation type. Majority of the treated patients (68.8%) have shown fast type of INH acetylation. After similar dose of isoniazid different profile of absorption and excretion of the drug and significant differences (p < 0.01) in INH concentrations, acetylation rate and bioavailability between 163 fast and 74 slow acetylators have been observed. In plasma of 38.6% fast acetylators drug concentration 3h after ingestion of the dose did not achieve the concentration of 1 mcg/ml. In plasma of 29.7% slow acetylators, concentrations of INH 6h after ingestion were higher than 2 mcg/ml.

摘要

在华沙国家结核病和肺部疾病研究所(NTLDRI),对237例接受300毫克剂量异烟肼标准疗程化疗的结核病患者的乙酰化类型进行了研究。在给药前(时间0)以及给药后1、3、6和24小时采集血样。采用生物学方法测定异烟肼的血浆浓度。使用两个乙酰化率指标——I3和C6来确定乙酰化类型。大多数接受治疗的患者(68.8%)表现为异烟肼快速乙酰化类型。给予相似剂量的异烟肼后,观察到163名快速乙酰化者和74名慢速乙酰化者之间药物的吸收和排泄情况不同,异烟肼浓度、乙酰化率和生物利用度存在显著差异(p < 0.01)。在38.6%的快速乙酰化者血浆中,服药后3小时药物浓度未达到1微克/毫升。在29.7%的慢速乙酰化者血浆中,服药后6小时异烟肼浓度高于2微克/毫升。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验